272 related articles for article (PubMed ID: 20646597)
1. [Expression and regulation of retinol binding protein 4 mRNA in human adipose tissue in obese and type 2 diabetics].
Liu XH; Wei L; Wang LY; Zhu CY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1251-4. PubMed ID: 20646597
[TBL] [Abstract][Full Text] [Related]
2. [Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance].
Lu HY; Li XF; Mu PW; Jiang W; Zeng LY
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3395-8. PubMed ID: 21223811
[TBL] [Abstract][Full Text] [Related]
3. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
4. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
5. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children.
Friebe D; Neef M; Erbs S; Dittrich K; Kratzsch J; Kovacs P; Blüher M; Kiess W; Körner A
Int J Pediatr Obes; 2011 Jun; 6(2-2):e345-52. PubMed ID: 20950077
[TBL] [Abstract][Full Text] [Related]
6. Decorin is a secreted protein associated with obesity and type 2 diabetes.
Bolton K; Segal D; McMillan J; Jowett J; Heilbronn L; Abberton K; Zimmet P; Chisholm D; Collier G; Walder K
Int J Obes (Lond); 2008 Jul; 32(7):1113-21. PubMed ID: 18414424
[TBL] [Abstract][Full Text] [Related]
7. Retinol-binding protein 4 in adipose and placental tissue of women with gestational diabetes.
Kuzmicki M; Telejko B; Wawrusiewicz-Kurylonek N; Nikolajuk A; Zwierz-Gugala D; Jelski W; Kolodziejczak M; Zonenberg A; Wilczynski J; Kretowski A; Gorska M; Szamatowicz J
Gynecol Endocrinol; 2011 Dec; 27(12):1065-9. PubMed ID: 21609194
[TBL] [Abstract][Full Text] [Related]
8. Retinol-binding protein 4 in human obesity.
Janke J; Engeli S; Boschmann M; Adams F; Böhnke J; Luft FC; Sharma AM; Jordan J
Diabetes; 2006 Oct; 55(10):2805-10. PubMed ID: 17003346
[TBL] [Abstract][Full Text] [Related]
9. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.
Klöting N; Berndt J; Kralisch S; Kovacs P; Fasshauer M; Schön MR; Stumvoll M; Blüher M
Biochem Biophys Res Commun; 2006 Jan; 339(1):430-6. PubMed ID: 16298335
[TBL] [Abstract][Full Text] [Related]
10. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
[TBL] [Abstract][Full Text] [Related]
11. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
[TBL] [Abstract][Full Text] [Related]
13. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes.
Erikstrup C; Mortensen OH; Nielsen AR; Fischer CP; Plomgaard P; Petersen AM; Krogh-Madsen R; Lindegaard B; Erhardt JG; Ullum H; Benn CS; Pedersen BK
Diabetes Obes Metab; 2009 Mar; 11(3):204-12. PubMed ID: 19215278
[TBL] [Abstract][Full Text] [Related]
14. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
[TBL] [Abstract][Full Text] [Related]
15. Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue.
Salgado-Somoza A; Teijeira-Fernández E; Rubio J; Couso E; González-Juanatey JR; Eiras S
Clin Endocrinol (Oxf); 2012 Jan; 76(1):51-8. PubMed ID: 21645024
[TBL] [Abstract][Full Text] [Related]
16. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue.
Wu H; Wei L; Bao Y; Lu J; Huang P; Liu Y; Jia W; Xiang K
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E628-34. PubMed ID: 19088257
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha.
Dahlman I; Forsgren M; Sjögren A; Nordström EA; Kaaman M; Näslund E; Attersand A; Arner P
Diabetes; 2006 Jun; 55(6):1792-9. PubMed ID: 16731844
[TBL] [Abstract][Full Text] [Related]
19. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities.
Miranda M; Ceperuelo-Mallafré V; Lecube A; Hernandez C; Chacon MR; Fort JM; Gallart L; Baena-Fustegueras JA; Simó R; Vendrell J
Metabolism; 2009 Dec; 58(12):1762-8. PubMed ID: 19615702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
